MedPath
Found 3 clinical trials|View Analysis
Sort by:

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

Phase 2
Recruiting
Conditions
Melanoma, Uveal
Uveal Neoplasms
Interventions
Biological: Tumor Infiltrating Lymphocytes (TIL)
First Posted Date
2018-03-16
Last Posted Date
2024-06-24
Lead Sponsor
Udai Kammula
Target Recruit Count
47
Registration Number
NCT03467516
Locations
🇺🇸

UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States

The Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver Metastases

Phase 3
Completed
Conditions
Melanoma
Uveal Neoplasms
Interventions
Procedure: IHP
First Posted Date
2013-02-07
Last Posted Date
2024-01-26
Lead Sponsor
Vastra Gotaland Region
Target Recruit Count
93
Registration Number
NCT01785316
Locations
🇸🇪

Sahlgrenska University Hospital, Gothenburg, Sweden

Validation of a Molecular Prognostic Test for Eye Melanoma

Withdrawn
Conditions
Choroid Neoplasms
Iris Neoplasms
Uveal Neoplasms
First Posted Date
2006-12-04
Last Posted Date
2018-06-26
Lead Sponsor
Washington University School of Medicine
Registration Number
NCT00406120
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath